WellsCare Inc., a leading South Korean med-tech innovator in wearable cold-laser therapy, has signed a supply agreement with SolnanoMed Co., a Thailand-based medical device distributor. The agreement follows WellsCare's recent FDA Thai approval for its flagship product, IASO Coldlaser — advanced photobiomodulation (PBM) therapy device designed for effective, drug-free pain management.
Through this partnership, SolnanoMed will serve as WellsCare's exclusive distributor in Thailand, covering hospitals, clinics, and retail channels nationwide. Together, the two companies aim to make hospital-grade pain-relief technology accessible for everyday users, empowering both healthcare professionals and consumers with convenient, wearable PBM solutions.
WellsCare's IASO Series harnesses low-level laser light to stimulate cellular recovery, reduce inflammation, and alleviate pain — all without medication or side effects. Unlike traditional therapy devices, IASO's compact, hands-free design allows users to receive continuous PBM treatment anytime, anywhere. The IASO Ultra, WellsCare's premium model, offers enhanced laser output, app connectivity, and multi-zone coverage, redefining how patients manage chronic and acute pain at home.
With award-winning recognition from international platforms such as CES and iF Design, WellsCare continues to expand its presence across North America and Asia through strategic partnerships and regulatory milestones.
